Drugplain

Anubis Barcelona 1.756 mL/5mL

Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin · CONCENTRATE · ANUBIS COSMETICS SL

No Recall History
Plain English

Anubis Barcelona is a concentrate containing peg-40 hydrogenated castor oil, propylene glycol, allantoin at 1.756 mL/5mL, taken topical. Manufactured by ANUBIS COSMETICS SL.

Key Facts

Brand Name
Anubis Barcelona
Generic Name
Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin
NDC Code (Product)
83021-617
Manufacturer
ANUBIS COSMETICS SL
Strength
1.756 mL/5mL
Dosage Form
CONCENTRATE
Route
TOPICAL
Marketing Status
Application #
M006
Drug Class
Standardized Chemical Allergen [EPC]
Marketing Start
10/21/2022

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

fatigue7 reports
headache7 reports
arthralgia6 reports
insomnia6 reports
drug ineffective5 reports
feeling abnormal5 reports
pain5 reports
anxiety4 reports
weight decreased4 reports
arthritis3 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

NE Lotion Indications

Dosage & Administration

NE Lotion dosage

Warnings

NE Lotion warnings

Frequently Asked Questions

What is Anubis Barcelona used for?

Anubis Barcelona contains Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin. It is a concentrate taken topical. Consult your doctor for specific uses.

Is Anubis Barcelona a controlled substance?

Anubis Barcelona is not classified as a controlled substance by the DEA.

What is the generic name for Anubis Barcelona?

The generic name for Anubis Barcelona is Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin. There are no other listed brand versions of Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin.

What is the NDC code for Anubis Barcelona 1.756 mL/5mL?

The NDC (National Drug Code) for Anubis Barcelona 1.756 mL/5mL is 83021-617, listed by ANUBIS COSMETICS SL.

Product NDC

83021-617

Package NDC

83021-617-05

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)